A detailed history of Advisory Services Network, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisory Services Network, LLC holds 4,793 shares of REGN stock, worth $3.42 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,793
Previous 4,793 -0.0%
Holding current value
$3.42 Million
Previous $5.04 Million 0.02%
% of portfolio
0.1%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $181,056 - $219,593
205 Added 4.47%
4,793 $5.04 Million
Q1 2024

May 06, 2024

SELL
$902.69 - $993.35 $95,685 - $105,295
-106 Reduced 2.26%
4,588 $4.42 Million
Q4 2023

Feb 09, 2024

BUY
$775.18 - $881.7 $231,003 - $262,746
298 Added 6.78%
4,694 $4.12 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $65,782 - $80,215
95 Added 2.21%
4,396 $3.62 Million
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $107,804 - $127,873
154 Added 3.71%
4,301 $3.09 Million
Q1 2023

May 17, 2023

SELL
$680.49 - $826.97 $139,500 - $169,528
-205 Reduced 4.71%
4,147 $3.41 Million
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $110,824 - $120,323
-157 Reduced 3.48%
4,352 $3.14 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $36,734 - $46,356
-64 Reduced 1.4%
4,509 $3.11 Million
Q2 2022

Aug 02, 2022

SELL
$548.35 - $738.84 $168,891 - $227,562
-308 Reduced 6.31%
4,573 $2.7 Million
Q1 2022

May 23, 2022

SELL
$595.12 - $698.43 $254,711 - $298,928
-428 Reduced 8.06%
4,881 $3.41 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $596,197 - $736,054
-1,097 Reduced 17.12%
5,309 $3.35 Million
Q3 2021

Nov 05, 2021

BUY
$574.03 - $680.96 $865,063 - $1.03 Million
1,507 Added 30.76%
6,406 $3.88 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $1.5 Million - $1.77 Million
3,175 Added 184.16%
4,899 $2.74 Million
Q1 2021

May 24, 2021

SELL
$446.73 - $548.2 $376,593 - $462,132
-843 Reduced 32.84%
1,724 $816,000
Q4 2020

Feb 09, 2021

BUY
$478.3 - $607.98 $212,843 - $270,551
445 Added 20.97%
2,567 $1.24 Million
Q3 2020

Nov 16, 2020

SELL
$544.75 - $658.21 $1.09 Million - $1.32 Million
-1,998 Reduced 48.5%
2,122 $1.19 Million
Q2 2020

Aug 10, 2020

BUY
$493.32 - $643.92 $952,107 - $1.24 Million
1,930 Added 88.13%
4,120 $2.57 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $492,503 - $724,339
1,465 Added 202.07%
2,190 $1.07 Million
Q4 2019

Feb 04, 2020

SELL
$274.13 - $376.51 $47,972 - $65,889
-175 Reduced 19.44%
725 $273,000
Q2 2019

Aug 01, 2019

SELL
$299.6 - $414.82 $1.05 Million - $1.45 Million
-3,507 Reduced 79.58%
900 $0
Q1 2019

May 20, 2019

BUY
$372.08 - $439.57 $1.31 Million - $1.54 Million
3,513 Added 392.95%
4,407 $1.81 Million
Q4 2018

Feb 15, 2019

BUY
$335.82 - $403.04 $77,574 - $93,102
231 Added 34.84%
894 $333,000
Q2 2018

Jul 27, 2018

BUY
$284.6 - $344.99 $78,834 - $95,562
277 Added 71.76%
663 $248,000
Q1 2018

Apr 23, 2018

SELL
$315.82 - $393.78 $19,265 - $24,020
-61 Reduced 13.65%
386 $0
Q4 2017

Feb 08, 2018

BUY
$358.63 - $469.95 $95,395 - $125,006
266 Added 146.96%
447 $168,000
Q3 2017

Oct 12, 2017

BUY
$431.38 - $504.0 $56,942 - $66,528
132 Added 269.39%
181 $81,000
Q2 2017

Aug 17, 2017

BUY
N/A
49
49 $24,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.